Comparison between Rolex Rings IPO and Tatva Chintan Pharma Chem IPO.
Rolex Rings IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Tatva Chintan Pharma Chem IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Rolex Rings IPO is up to ₹731.00 Cr whereas the issue size of the Tatva Chintan Pharma Chem IPO is up to ₹500.00 Cr. The final issue price of Rolex Rings IPO is ₹900.00 per share and of Tatva Chintan Pharma Chem IPO is ₹1,083.00 per share.
| Rolex Rings IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹880.00 per share | ₹1,073.00 per share |
| Issue Price (Upper) | ₹900.00 per share | ₹1,083.00 per share |
| Issue Price (Final) | ₹900.00 per share | ₹1,083.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 16 shares | 13 shares |
| Fresh Issue Size | 6,22,222 shares | 20,77,562 shares |
| Fresh Issue Size (Amount) | up to ₹56.00 Cr | up to ₹225.00 Cr |
| OFS Issue Size | 75,00,000 shares | 25,39,242 shares |
| OFS Issue Size (Amount) | up to ₹675.00 Cr | up to ₹275.00 Cr |
| Issue Size Total | 81,22,222 shares | 46,16,804 shares |
| Issue Size Total (Amount) | up to ₹731.00 Cr | up to ₹500.00 Cr |
Rolex Rings IPO opens on Jul 28, 2021, while Tatva Chintan Pharma Chem IPO opens on Jul 16, 2021. The closing date of Rolex Rings IPO and Tatva Chintan Pharma Chem IPO is Jul 30, 2021, and Jul 20, 2021, respectively.
| Rolex Rings IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| Anchor Bid Date | Jul 27, 2021 | Jul 15, 2021 |
| Issue Open | Jul 28, 2021 | Jul 16, 2021 |
| Issue Close | Jul 30, 2021 | Jul 20, 2021 |
| Basis Of Allotment (Tentative) | Aug 04, 2021 | Jul 26, 2021 |
| Initiation of Refunds (Tentative) | Aug 05, 2021 | Jul 27, 2021 |
| Credit of Share (Tentative) | Aug 06, 2021 | Jul 28, 2021 |
| Listing date (Tentative) | Aug 09, 2021 | Jul 29, 2021 |
| Anchor Lockin End date 1 | Sep 03, 2021 | Aug 25, 2021 |
| Anchor Lockin End date 2 | Nov 02, 2021 | Oct 24, 2021 |
Rolex Rings IPO P/E ratio is , as compared to Tatva Chintan Pharma Chem IPO P/E ratio of .
| Rolex Rings IPO | Tatva Chintan Pharma Chem IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 58.99 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 57.64 | 79.17 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹2451.00 Cr. | ₹2400.48 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Rolex Rings IPO Retail Individual Investors (RII) are offered 28,42,778 shares while in Tatva Chintan Pharma Chem IPO retail investors are offered 28,42,778 shares. Qualified Institutional Buyers (QIB) are offered 16,24,444 shares in Rolex Rings IPO and 9,23,361 shares in Tatva Chintan Pharma Chem IPO.
| Rolex Rings IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| Anchor Investor Reservation | 24,36,666 shares | 13,85,040 shares |
| Market Maker Reservation | ||
| QIB | 16,24,444 shares | 9,23,361 shares |
| NII | 12,18,334 shares | 6,92,521 shares |
| RII | 28,42,778 shares | 16,15,882 shares |
| Employee | ||
| Others | ||
| Total | 81,22,222 shares | 46,16,804 shares |
Rolex Rings IPO subscribed 130.44x in total, whereas Tatva Chintan Pharma Chem IPO subscribed 180.36x.
| Rolex Rings IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| QIB (times) | 143.58x | 185.23x |
| NII (times) | 360.11x | 512.22x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 24.49x | 35.35x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 130.44x | 180.36x |
